BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen X, Kunda PE, Lin J, Zhou M, Huang J, Zhang H, Liu T. SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma. J Cancer Res Clin Oncol 2018;144:675-84. [PMID: 29372378 DOI: 10.1007/s00432-018-2584-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Schefler AC, Kim RS. Recent advancements in the management of retinoblastoma and uveal melanoma. Fac Rev 2021;10:51. [PMID: 34195690 DOI: 10.12703/r/10-51] [Reference Citation Analysis]
2 Singh L, Singh MK, Rizvi MA, Bakhshi S, Meel R, Lomi N, Sen S, Kashyap S. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma. Cancer Immunol Immunother 2020;69:1087-99. [PMID: 32100078 DOI: 10.1007/s00262-020-02529-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Wang H, Yang J, Pan H, Tai MC, Maher MH, Jia R, Ge S, Lu L. Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway. Onco Targets Ther 2020;13:3903-20. [PMID: 32440155 DOI: 10.2147/OTT.S228532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cao Y, Zhou Y, Chen Z, Zhang Z, Chen X, He C. Localized Chemotherapy Based on Injectable Hydrogel Boosts the Antitumor Activity of Adoptively Transferred T Lymphocytes In Vivo. Adv Healthc Mater 2021;:e2100814. [PMID: 34297480 DOI: 10.1002/adhm.202100814] [Reference Citation Analysis]
5 Sun L, Hao Y, Wang Z, Zeng Y. Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines. Viruses 2018;10:E145. [PMID: 29570629 DOI: 10.3390/v10040145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Chen X, Wen F, Li Z, Li W, Zhou M, Sun X, Zhao P, Zou C, Liu T. Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL. Cancer Med 2022. [PMID: 35488386 DOI: 10.1002/cam4.4712] [Reference Citation Analysis]